About Us
Ever since our founding, we have evolved in response to changing times, always seeking to support the health of our customers.
Brief History
PT Taisho Pharmaceutical Indonesia Tbk (the "Company") was initially established as PT Squibb Indonesia in 1970. The Company commenced commercial operations in 1972. The Company was running in pharmaceutical industry, produced Over- the- Counter (" OTC") and Ethical products, both for domestic and export markets. In accordance with article 3 of the Company's Articles of Association, the Company's activities are to develop, register, process, produce and sell chemical, pharmaceutical and health care products. In 2009, the ownership of the Company acquired by Taisho Pharmaceutical Co. Ltd., a company incorporated in Japan. Our head office is located at Millennium Centennial Center 8th floor, Jl. Jend. Sudirman Kav. 25, Jakarta 12920. The Company's manufacturing plant is located at JI. Raya Bogor Km. 38, Cilangkap Depok – 16958.
TPI Whistleblowing Service
As a member of Taisho Pharmaceutical Co., Ltd. group, PT Taisho Pharmaceutical Indonesia Tbk. (“TPI”) adopted the Corporate Code of Conduct and implement in doing the Company’s day to day activities. In relation to the above matter, TPI provides opportunities to its employees and stakeholders to participate
in monitoring the Company’s activities by launching TPI Whistleblowing Service.
TPI Whistleblowing Service is a whistleblowing system managed professionally and independently which can be accessed by all employees and stakeholders of TPI to report allegation of misconduct on the principles and guidelines for corporate behavior regulated in the applicable Code of Conducts.
Scope of the Policy and Procedure
Scope of allegations that will be followed up by TPI Whistleblowing Service includes the following:- Fraud
- Corruption
- Theft
- Breach of the company policy and regulation, including:
- Code of Conducts
- Conflict of interest
- Bribery/Gratification
- Illegal activities